Substance P interactions with the nicotinic response.
Livett
B G
BG
Department of Biochemistry, University of Melbourne, Parkville, Victoria, Australia.
Zhou
X F
XF
D000311:Adrenal Glands / Q000187:drug effects / Q000502:physiology*; D000313:Adrenal Medulla / Q000187:drug effects / Q000502:physiology*; D000595:Amino Acid Sequence; D000818:Animals; D002217:Carbachol / Q000494:pharmacology; D002417:Cattle; D002478:Cells, Cultured; D066298:In Vitro Techniques; D008969:Molecular Sequence Data; D009538:Nicotine / Q000494:pharmacology*; D009638:Norepinephrine / Q000378:metabolism; D016716:PC12 Cells; D010446:Peptide Fragments / Q000494:pharmacology; D051381:Rats; D011978:Receptors, Nicotinic / Q000187:drug effects / Q000502:physiology*; D012964:Sodium / Q000378:metabolism; D013329:Structure-Activity Relationship; D013373:Substance P / Q000031:analogs & derivatives* / Q000494:pharmacology*
D010446:Peptide Fragments; D011978:Receptors, Nicotinic; D013373:Substance P; D009538:Nicotine; D002217:Carbachol; D012964:Sodium; D009638:Norepinephrine